Phibro Animal Health (PAHC) Short-term Investments (2017 - 2026)

Phibro Animal Health has reported Short-term Investments for 10 years, with the latest figure at $20.6 million in Q2 2026.

• On a quarterly basis, Short-term Investments rose 128.61% year-over-year to $20.6 million in Q2 2026; TTM through Jun 2026 was $20.6 million, a 128.61% increase from a year earlier, with the FY2026 full-year figure at $20.6 million, up 128.61% from the prior year.
• Short-term Investments was $20.6 million for Q2 2026 at Phibro Animal Health, down from $22.5 million in the prior quarter.
• The five-year high for Short-term Investments was $59.5 million in Q4 2023, with the low at $9.0 million in Q2 2025.
• Average Short-term Investments over 5 years is $27.7 million, with a median of $22.1 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2023: Short-term Investments tumbled 82.14% in 2022, then soared 495.23% in 2023.
• Over 5 years, Short-term Investments stood at $10.0 million in 2022, then jumped by 495.23% to $59.5 million in 2023, then slumped by 36.16% to $38.0 million in 2024, then plunged by 49.94% to $19.0 million in 2025, then climbed by 8.16% to $20.6 million in 2026.
• The last three Short-term Investments figures came in at $20.6 million (Q2 2026), $22.5 million (Q1 2026), and $19.0 million (Q4 2025), per Business Quant data.